Oxidative Stress Protection Mechanism of Taxifolin in H9C2 Cells
1.Department of Pediatrics,the Third Xiangya Hospital of Central South University,Changsha 410006,China
2.Center for Heart Development,Hunan Normal University/Key Laboratory of Protein Chemistry and Fish Developmental Biology,Changsha 410006,China
3.Guangdong Cardiovascular Institute/Guangdong General Hospital/Guangdong Academy of Medical Sciences,Guangzhou 510000,China
*Corresponding author:ZHAO Mingyi,Master supervisor,Assistant research fellow;E-mail:36163773@qq.com
[1]BARQUERA S,PEDROZA-TOBíAS A,MEDINA C,et al.Global overview of the epidemiology of atherosclerotic cardiovascular disease[J].Arch Med Res,2015,46(5):328-338.DOI:10.1016/j.arcmed.2015.06.006.
[2]LI H,SONG F,DUAN L R,et al.Paeonol and danshensu combination attenuates apoptosis in myocardial infarcted rats by inhibiting oxidative stress:roles of Nrf2/HO-1 and PI3K/Akt pathway[J].Sci Rep,2016,6:23693.DOI:10.1038/srep23693.
[3]韩晓燕.NADPH氧化酶NOX家族与疾病的关系[J].国际病理科学与临床杂志,2010,30(6):513-517.DOI:10.3969/j.issn.1673-2588.2010.06.012.
HAN X Y.NOX family of NADPH oxidase and diseases[J].Journal of International Pathology and Clinical Medicine,2010,30(6):513-517.DOI:10.3969/j.issn.1673-2588.2010.06.012.
[4]陈丽云,吴艳青,张正红,等.NADPH氧化还原反应平台及其在AngⅡ介导ROS信号通路中的调节作用[J].生理科学进展,2012,43(6):439-444.DOI:10.3969/j.issn.0559-7765.2012.06.008.
CHEN L Y,WU Y Q,ZHANG Z H,et al.NADPH redox reaction platform and its regulatory role in AngⅡ-mediated ROS signaling pathway[J].Progress in Physiological Sciences,2012,43(6):439-444.DOI:10.3969/j.issn.0559-7765.2012.06.008.
[5]BRAUNERSREUTHER V,MONTECUCCO F,ASRIH M,et al.
Role of NADPH oxidase isoforms NOX1,NOX2 and NOX4 in myocardial ischemia/reperfusion injury[J].J Mol Cell Cardiol,2013,64:99-107.DOI:10.1016/j.yjmcc.2013.09.007.
[6]仝瑶瑶,刘晖.花旗松素的研究进展[J].中西医结合心血管病电子杂志,2014,2(3):139-140.
TONG Y Y,LIU H.Advances in research of Taxifolin[J].Cardiovascular Disease Journal of Integrated Traditional Chinese and Western Medicine,2014,2(3):139-140.
[7]张昊,陈芳,申杰.P38MAPK信号通路及其与动物氧化应激反应关系的研究进展[J].湖北畜牧兽医,2015,36(7):13-15.DOI:10.3969/j.issn.1007-273X.2015.07.005.
ZHANG H,CHEN F,SHEN J.P38MAPK signaling pathway and its relationship with animal oxidative stress in animals[J].Hubei Journal of Animal and Veterinary Sciences,2015,36(7):13-15.DOI:10.3969/j.issn.1007-273X.2015.07.005.
[8]SONG J,LIU Q,TANG H,et al.Activation of PI3Kγ/Akt pathway increases cardiomyocyte HMGB1 expression in diabetic environment[J].Oncotarget,2016,7(49):80803-80810.DOI:10.18632/oncotarget.13096.
[9]师智勇,孙宗全,王国华.花旗松素对大鼠心肌缺血再灌注损伤的保护作用[J].华中医学杂志,2008,32(4):287-289.
SHI Z Y,SUN Z Q,WANG G H.The study of Taxifolin's effect on myocardial ischemia-reperfusion injury in rats[J].Central China Medical Journal,2008,32(4):287-289.
[10]苏其利,朱平,庄建,等.氧化应激与缺血性心肌病的研究进展[J].岭南心血管病杂志,2017,23(5):628-632.DOI:10.3969/j.issn.1007-9688.2017.05.36.
SU Q L,ZHU P,ZHUANG J,et al.Advances in oxidative stress and ischemic cardiomyopathy[J].South China Journal of Cardiovascular Diseases,2017,23(5):628-632.DOI:10.3969/j.issn.1007-9688.2017.05.36.
[11]马丽雅,张辉锋.一氧化氮合酶(NOS)与心血管疾病[J].临床医学研究,2010,27(2):349-352.DOI:10.3969/j.issn.1671-7171.2010.02.063.
MA L Y,ZHANG H F.Nitric oxide synthase(NOS)and cardiovascular disease[J].Journal of Clinical Research,2010,27(2):349-352.DOI:10.3969/j.issn.1671-7171.2010.02.063.
[12]DENHARDT D T,GIACHELLI C M,RITTLING S R.Role of osteopontin in cellular signaling and toxicant injury[J].Annu Rev Pharmacol Toxicol,2001,41:723-749.DOI:10.1146/annurev.pharmtox.41.1.723.
[13]魏露观.影响细胞毒性T淋巴细胞在病毒性心肌炎中分布的相关研究[D].大连:大连医科大学,2013.
WEI L G.Study on the distribution of cytotoxic T lymphocyte in viral myocarditis[D].Dalian:Dalian Medical University,2013.
[14]罗俊,苏威,朱腾腾,等.特发性肺动脉高压患者血清高迁移率族蛋白B1水平及其临床意义[J].中山大学学报(医学科学版),2017,38(6):860-865.
LUO J,SU W,ZHU T T,et al.Serum HMGB1 levels and its clinical significance in patients with idiopathic pulmonary arterial hypertension[J].Journal of Sun Yat-sen University(Medical Sciences),2017,38(6):860-865.
[15]NAVARRO-GONZáLEZ J F,MORA-FERNáNDEZ C,MUROS DE FUENTES M,et al.Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy[J].Nat Rev Nephrol,2011,7(6):327-340.DOI:10.1038/nrneph.2011.51.
[16]KLUNE J R,DHUPAR R,CARDINAL J,et al.HMGB1:endogenous danger signaling[J].Mol Med,2008,14(7/8):476-484.DOI:10.2119/2008-00034.Klune.
[17]MAGNA M,PISETSKY D S.The role of HMGB1 in the pathogenesis of inflammatory and autoimmune diseases[J].Mol Med,2014,20:138-146.DOI:10.2119/molmed.2013.00164.
[18]PORTO A,PALUMBO R,PIERONI M,et al.Smooth muscle cells in human atherosclerotic plaques secrete and proliferate in response to high mobility group box 1 protein[J].FASEB J,2006,20(14):2565-2566.DOI:10.1096/fj.06-5867fje.
[19]INOUE K,KAWAHARA K,BISWAS K K,et al.HMGB1 expression by activated vascular smooth muscle cells in advanced human atherosclerosis plaques[J].Cardiovasc Pathol,2007,16(3):136-143.DOI:10.1016/j.carpath.2006.11.006.
[20]宋琦,王振杰.MAPK信号转导通路与失血性休克相关性的研究进展[J].中国急救医学,2018,38(8):684-689.DOI:10.3969/j.issn.1002-1949.2018.08.009.
SONG Q,WANG Z J.Progress of relationship between MAPK signal transduction pathway and hemorrhagic shock[J].Chinese Journal of Critical Care Medicine,2018,38(8):684-689.DOI:10.3969/j.issn.1002-1949.2018.08.009.
[21]LIU F C,LEE H C,LIAO C C,et al.Tropisetron protects against acetaminophen-induced liver injury via suppressing hepatic oxidative stress and modulating the activation of JNK/ERK MAPK pathways[J].Biomed Res Int,2016,2016:1952947.DOI:10.1155/2016/1952947.